The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Toshio Imanishi

Department of Cardiovascular Medicine

Wakayama Medical University

811-1 Kimiidera

Wakayama City

Japan

[email]@wakayama-med.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Cardiovascular Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Japan. 2002 - 2010

References

  1. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Imanishi, T., Ikejima, H., Tsujioka, H., Kuroi, A., Ishibashi, K., Komukai, K., Tanimoto, T., Ino, Y., Takeshita, T., Akasaka, T. Atherosclerosis (2010) [Pubmed]
  2. Endothelial progenitor cell senescence--is there a role for estrogen?. Imanishi, T., Tsujioka, H., Akasaka, T. Ther. Adv. Cardiovasc. Dis (2010) [Pubmed]
  3. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Imanishi, T., Tsujioka, H., Ikejima, H., Kuroi, A., Takarada, S., Kitabata, H., Tanimoto, T., Muragaki, Y., Mochizuki, S., Goto, M., Yoshida, K., Akasaka, T. Hypertension (2008) [Pubmed]
  4. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit. Imanishi, T., Kuroi, A., Ikejima, H., Kobayashi, K., Mochizuki, S., Goto, M., Yoshida, K., Akasaka, T. Hypertens. Res. (2008) [Pubmed]
  5. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Imanishi, T., Ikejima, H., Tsujioka, H., Tsujioka, A., Kuroi, A., Kobayashi, K., Shiomi, M., Muragaki, Y., Mochizuki, S., Goto, M., Yoshida, K., Akasaka, T. Hypertens. Res. (2008) [Pubmed]
  6. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits. Imanishi, T., Kuroi, A., Ikejima, H., Kobayashi, K., Muragaki, Y., Mochizuki, S., Goto, M., Yoshida, K., Akasaka, T. Hypertens. Res. (2008) [Pubmed]
  7. Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability. Imanishi, T., Ikejima, H., Tsujioka, H., Kuroi, A., Kobayashi, K., Muragaki, Y., Mochizuki, S., Goto, M., Yoshida, K., Akasaka, T. Hypertension (2008) [Pubmed]
  8. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell. Imanishi, T., Kobayashi, K., Kuroi, A., Ikejima, H., Akasaka, T. Hypertens. Res. (2008) [Pubmed]
  9. Evaluation of pharmacological modulation of nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor. Imanishi, T., Kuroi, A., Ikejima, H., Mochizuki, S., Goto, M., Akasaka, T. Circ. J. (2007) [Pubmed]
  10. Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor. Imanishi, T., Kobayashi, K., Kuroi, A., Mochizuki, S., Goto, M., Yoshida, K., Akasaka, T. Hypertension (2006) [Pubmed]
  11. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. Imanishi, T., Hano, T., Nishio, I. J. Hypertens. (2005) [Pubmed]
  12. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. Imanishi, T., Hano, T., Nishio, I. J. Hypertens. (2005) [Pubmed]
  13. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Imanishi, T., Hano, T., Nishio, I. Hypertens. Res. (2005) [Pubmed]
  14. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. Imanishi, T., Moriwaki, C., Hano, T., Nishio, I. J. Hypertens. (2005) [Pubmed]
  15. Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats. Imanishi, T., Kobayashi, K., Hano, T., Nishio, I. Hypertens. Res. (2005) [Pubmed]
  16. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Imanishi, T., Hano, T., Nishio, I. Hypertens. Res. (2004) [Pubmed]
  17. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Imanishi, T., Hano, T., Sawamura, T., Nishio, I. Clin. Exp. Pharmacol. Physiol. (2004) [Pubmed]
  18. Inhibition of nuclear translocation of transcription factor nuclear factor-kappa B induces FAS- as well as tumour necrosis factor-alpha-mediated apoptosis through downregulation of a conserved family of inhibitor of apoptosis 1. Imanishi, T., Hano, T., Takarada, S., Nishio, I. Clin. Exp. Pharmacol. Physiol. (2003) [Pubmed]
  19. Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Imanishi, T., Hano, T., Matsuo, Y., Nishio, I. Clin. Exp. Pharmacol. Physiol. (2003) [Pubmed]
  20. Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Imanishi, T., Hano, T., Sawamura, T., Takarada, S., Nishio, I. Circ. J. (2002) [Pubmed]
 
WikiGenes - Universities